Assessment of fetal intracranial pathologies first demonstrated late in pregnancy: cell proliferation disorders by Malinger, Gustavo et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
Reproductive Biology and 
Endocrinology
Open Access Review
Assessment of fetal intracranial pathologies first demonstrated late 
in pregnancy: cell proliferation disorders
Gustavo Malinger*1,2, Dorit Lev1,3 and Tally Lerman-Sagie1,4
Address: 1Fetal Neurology Clinic, Edith Wolfson Medical Center, Holon & Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, 
2Prenatal Diagnosis Unit, Department of Obstetrics and Gynecology, Edith Wolfson Medical Center, Holon & Sackler Faculty of Medicine, Tel Aviv 
University, Tel Aviv, Israel, 3Institute of Medical Genetics, Edith Wolfson Medical Center, Holon & Sackler Faculty of Medicine, Tel Aviv University, 
Tel Aviv, Israel and 4Pediatric Neurology Unit, Edith Wolfson Medical Center, Holon & Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 
Israel
Email: Gustavo Malinger* - malinger@inter.net.il; Dorit Lev - dorlev@post.tau.ac.il; Tally Lerman-Sagie - asagie@post.tau.ac.il
* Corresponding author    
Abstract
A considerable number of central nervous system pathologies remain undiagnosed during the first
two trimesters of pregnancy. This group of disorders includes anomalies of brain proliferation,
migration and cortical organization. Due to the fact that a detailed ultrasound examination of the
fetal brain is usually not performed during the third trimester the diagnosis of these disorders is
usually only made in families with a previously affected child or in many cases be mere chance. In
this article we review the feasibility of prenatal diagnosis of disorders of brain proliferation:
microcephaly, macrocephaly, hemimegalencephaly and neoplastic and non-neoplastic abnormal cell
types. We discuss the differential diagnosis and offer a stepwise approach to the diagnosis of the
more common disorders.
Review
Thirty years have passed since the first prenatal diagnosis
of a fetus with a brain malformation was made by ultra-
sound [1]. Since then, rapid development of new US
machines and transducers have established the basis for a
new field in Obstetrics: the diagnosis of congenital
anomalies[2].
Shortly after the report by Campbell et al [1] Kratochwil et
al diagnosed fetal hydrocephaly [3], Michell and Bradley-
Watson described a case of fetal meningocele [4] and Karp
et al reported the use of ultrasound for the exclusion of
primary microcephaly [5].
During the second half of the 70's and during the 80's
studies on the normal anatomy and biometry of the fetal
brain enabled prenatal screening for CNS malformations
[6-9].
By 1988 the now classical textbook on the prenatal diag-
nosis of congenital anomalies by Romero et al [2]
included a comprehensive chapter on the normal anat-
omy and pathology of the fetal CNS. In their book they
describe the ultrasonographic features of holoprosen-
cephaly, agenesis of the corpus callosum, intracranial
arachnoid cysts, and choroid plexus cysts.
One year later, Filly et al suggested the use of 3 specific
axial planes for the evaluation of the fetal CNS [10]. By
routine visualization of the transventricular, transtha-
lamic and transcerebellar planes, they were able to diag-
nose, retrospectively, most cases with CNS anomalies.
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Further progress was made after the introduction of high-
resolution transvaginal probes. Transvaginal ultrasound
permits the study of the brain in fetuses in vertex presen-
tation in planes that are usually difficult to obtain with the
transabdominal approach [11,12]. Recently, fetal mag-
netic resonance emerged as an additional potential useful
method for the diagnosis of CNS anomalies [13].
The modern approach to the diagnosis of fetal CNS
pathologies requires an in-depth knowledge of brain anat-
omy and embryology, expertise in the different imaging
techniques and proficiency in the different genetic aspects
of congenital brain disorders. Moreover, in order to estab-
lish the specific prognosis in a given case experience in
pediatric neurology is essential. These requirements can
only be met by a multidisciplinary team that includes
experts in the fields of fetal medicine, neuroradiology,
genetics, pediatric neurology, neonatology and pathology
[14].
A cornerstone in the understanding of the development of
the normal and pathologic brain is the understanding that
the brain develops as a continuum during pregnancy and
even after delivery and that different insults at a specific
time may produce similar pathologies [15]. The current
recommendation for screening of fetal anomalies is a sec-
ond trimester ultrasound examination between 19 and 22
weeks of pregnancy. However a substantial amount of sig-
nificant brain anomalies will remain undiagnosed at this
gestational age [16].
We present a structured approach to the diagnosis of late
manifesting fetal intracranial pathologies. In this first part
we review the different aspects of cell proliferation
disorders.
Brain Development
Volpe describes the sequential development of the human
brain [15]. Early events include dorsal and ventral induc-
tion while later events, occurring from the second month
of gestation through the postnatal period, include cell
proliferation, migration, organization and myelination.
New classifications based on information obtained from
MRI and genetic studies have recently been published
[17,18]. The classification system proposed by Barkovich
et al [17] is based on Volpe's framework [15] but expands
the sub-classifications. On the other hand, Sarnat [18]
proposed a new etiologic classification based fundamen-
tally on the different patterns of genetic expression of mal-
formations without consideration of the temporal pattern
of development.
The most useful classification for the fetal neurosonogra-
pher is the one proposed by Barkovich et al [17]. Descrip-
tion of the abnormal ultrasonographic findings in a
particular fetus enables categorization into one of the fol-
lowing entities: 1. Cell proliferation anomalies (i.e.
microcephaly, megalencephaly and hemimegalenceph-
aly); 2. Neuronal migration anomalies (i.e. lissencephaly,
cobblestone complex and heterotopia); or 3. Abnormal
cortical organization (i.e. polymicrogyria, schizencephaly
and cortical dysplasia).
Cell proliferation disorders
Microcephaly
Microcephaly is defined postnatally as low brain weight
and a small head circumference (HC) more than two
standard deviations (SD) below the mean or below the 3rd
percentile. Such a broad definition obviously includes
normal individuals. The smaller the head circumference,
the higher the chances of associated mental retardation.
Prenatally, there is no consensus regarding the exact defi-
nition of abnormally small HC, some authors propose the
-2SD [17] cutoff while others propose the -3SD [19] cut-
off. Using the -3SD definition, Chervenak et al showed
that the prenatal HC measurement was sensitive for diag-
nosis of microcephaly with no false negatives, -4SD was a
specific test with no false positive cases[19].
The incidence of microcephaly at birth is estimated to be
in the range between 1:6250 and 1:8500 deliveries. The
incidence is much higher, 1.6 per 1000 after the first year
of life [19] due to progressive microcephaly following
perinatal insults or due to a neurodegenerative metabolic
or neurogenetic process. Congenital microcephaly may
present as an isolated finding, in this case it is known as
primary microcephaly or microcephaly vera and be asso-
ciated with a wide range of CNS and non-CNS
pathologies[20].
The prenatal diagnosis of microcephaly, particularly in
cases of primary microcephaly, is usually difficult before
the 3rd trimester. Reece and Goldstein in a study of 9600
low risk pregnancies in which the brain was scanned for
congenital anomalies failed to diagnose all 5 cases of
microcephaly [21]. The authors did not state the gesta-
tional age in which the examinations were performed.
Bromely and Benacerraf [22] found that 6 out of 7 fetuses
with postnatally diagnosed microcephaly had normal
head size measurements before 22 weeks of pregnancy
and were diagnosed only after 27 weeks of gestation.
In some cases the presence of microcephaly may be sus-
pected based on additional sonographic findings like:
small frontal lobe [23], sloping forehead [24], enlarged
subarachnoid space [24,25] and/or abnormal power Dop-
pler demonstration of the anterior and middle cerebral
arteries [24].Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/110
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The accuracy of ultrasound in the diagnosis of microceph-
aly has not been studied prospectively. Two retrospective
analyses of cases diagnosed prenatally have recently been
reported. Den Hollander et al reported on 30 fetuses with
prenatally diagnosed microcephaly [26]. The main refer-
ral indications were: reduced head size or suspected IUGR
(16 fetuses), intracranial anomalies (5 fetuses), and
extracranial anomalies (3 fetuses). Mean gestational age at
the time of referral was 27 weeks and at the time of diag-
nosis 28 weeks. Associated anomalies were present in
83.3% of the patients: holoprosencephaly (16.7%), chro-
mosomal anomalies (23.3%), genetic syndromes (20%)
and multiple anomalies (23.3%). Only 5 patients were
considered to represent "isolated microcephaly" but a
careful analysis of these cases showed that 3 of them had
other minor anomalies, one was probably associated with
twin to twin transfusion syndrome with ventriculomegaly
and one was diagnosed in a family with a previous history
of microcephaly. The authors did not describe the number
of fetuses with microcephaly diagnosed after delivery in
their center.
Dahlgren and Wilson reviewed all cases of microcephaly
diagnosed during a 10-year period at British Columbia
Women's Hospital [27]. They found 45 cases; in 21, the
diagnosis was made prenatally and confirmed postna-
tally. In 15 patients, the second trimester ultrasound was
available and 12 of these patients had a normal scan
between 15 and 20 weeks of gestation. In 9 patients
(43%) the etiologic cause of microcephaly remained
unclear: possible viral infection based on placental signs
of villitis or chorioamnionitis (4), multiple malforma-
tions (1), constitutional (1) and no specific etiology iden-
tified (3).
The counseling dilemma for fetuses with a small HC
remains difficult. Mental retardation can safely be pre-
dicted in cases with associated US findings, abnormal
karyotype or positive test for intrauterine infection. In
fetuses with isolated small HC an effort should be made
to determine gyral normality in utero by US or MRI. Chil-
dren with severe primary microcephaly may have a sim-
plified gyral pattern that in the most severe cases may
resemble lissencephaly. It is noteworthy that this pattern
may develop late in pregnancy or even after delivery.
To illustrate this dilemma we present the HC growth
curves (Figure 1) of two fetuses suspected of having micro-
cephaly vera during pregnancy. Both fetuses were consid-
ered morphologically normal by US and MR
examinations. In these cases the family history was the
cornerstone for counseling. The mother of patient A has a
small HC (51 cm) and is of normal intelligence. Patient B
has a sibling with severe microcephaly and neurodevelop-
mental retardation and the parents are second cousins.
While patient A is neurologically normal at 18 months of
age and the HC continues to be below the 3rd percentile,
patient B suffers from microcephaly with profound neu-
rodevelopmental retardation. These examples illustrates
that the evaluation of the patient's family members is cru-
cial before counseling is attempted.
In fetuses with severe associated malformations, the diag-
nosis is made based on the presence of these anomalies
(Figure 2).
Primary microcephaly is genetically heterogeneous, with
several loci currently mapped [28]. The advances in iden-
tifying genes associated with brain development will ena-
ble future prenatal molecular diagnosis in families at risk.
The recurrence risk to parents of a child with primary
microcephaly is 25% [28]. The proposed prenatal investi-
gation of fetuses with microcephaly is presented in Figure
3.
Macrocephaly
Macrocephaly is defined as a head circumference above
the 98th percentile or more than 2 SD above the mean. In
the absence of hydrocephaly or enlarged subarachnoid
spaces it is synonymous with megalencephaly. In a study
of Swedish boys it was found in 0.5% of the population
and was associated with lower intelligence [29]. Other
investigators found that the vast majority of children with
megalencephaly have normal intelligence [30].
The most common form of megalencephaly is autosomal
dominant and familial, and usually not associated with
mental retardation. Yet, megalencephaly may be associ-
ated with many syndromes [20,31].
The prenatal diagnosis of macrocephaly has been occa-
sionally reported [16,32,33]. The differential diagnosis in
these cases is difficult. The demonstration of an enlarged
subarachnoid space, particularly in the frontal region, in a
fetus with macrocephaly is suggestive of benign enlarge-
ment of the subarachnoid spaces and is usually associated
with a good prognosis (when the head circumference is
normal or low enlarged subarachnoid spaces may imply
brain atrophy) [25].
An essential part of the evaluation is measurement of the
parents' head circumference. When one parent has a large
head circumference it is not immediately reassuring that
the fetus has benign familial macrocephaly, since several
syndromes which may combine macrocephaly and men-
tal retardation, can be inherited in an autosomal domi-
nant fashion while the affected parent may only present
with macrocephaly. These syndromes include Neurofi-
bromatosis type 1 (NF1) [34], Sotos syndrome [33,35],
Weaver syndrome [35], Cole-Hughes syndrome [36], andReproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/110
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Head circumference growth curves in 2 fetuses with suspected microcephaly vera Figure 1
Head circumference growth curves in 2 fetuses with suspected microcephaly vera. Patient A is neurologically normal at 18 
months of age. Patient B suffers from severe neurodevelopmental retardation at 12 months of age.Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/110
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the inherited macrocephaly-hamartomas syndrome due
to PTEN mutations [37]. Therefore, a careful medical his-
tory of the affected parent should be obtained regarding
neurological problems, developmental milestones, skin
abnormalities, endocrine disorders and propensity for the
development of tumors. The parent with macrocephaly
should be examined with special attention to the skin
(lipomas, macules, café au lait spots, neurofibromas) and
dysmorphic features. If there are specific findings in the
parent, molecular diagnosis is now possible for NF1,
Sotos syndrome and macrocephaly-hamartomas syn-
dromes. A large head circumference of the fetus is even
more alarming when the parents have a normal head cir-
cumference. When it is associated with overgrowth both
Sotos and Weaver syndromes should be considered
because most cases are sporadic. When it is observed in a
fetus with short femur, skeletal dysplasias such as achon-
droplasia and hypochondroplasia are possible [16].
The flow chart for the investigation of fetuses with mega-
lencephaly is presented in Figure 4.
Abnormal proliferation with abnormal cell types
According to the classification proposed by Barkovich et al
[17] this category includes: non-neoplastic and neoplastic
abnormal cell types. The non-neoplastic category includes
3 different entities: cortical hamartomas of tuberous scle-
rosis, cortical dysplasia with balloon cells and hemimega-
lencephaly. The neoplastic category also includes 3
different entities: dysembryoplastic neuroepithelial
tumors, ganglioglioma and gangliocytoma.
Severe microcephaly with associated brain atrophy at 24 weeks Figure 2
Severe microcephaly with associated brain atrophy at 24 weeks. The brain parenchyma is atrophic and echoegenic (arrow) 
with ventriculomegaly (v) and enlarged subarachnoid space (s).Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/110
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Flow chart in patients with suspected microcephaly Figure 3
Flow chart in patients with suspected microcephaly.
Head Circumference < 2SD
Consanguinity, familial history
HC measurement of parents & siblings
Positive history of 
child with 
microcephaly & MR
 Recurrence risk ~ 100% 
Familial small HC
Normal intelligence
Good prognosis
Follow up every 3 wks
No history
Normal parental HC
Fetal Neurosonography
Karyotype
TORCH
If HC< 3SD:
Fetal brain MRI
No associated anomalies
If abnormal (Lissencephaly,
simplified gyral pattern)
MR = 100%
If normal 
Associated anomalies
Prognosis according to 
syndromic diagnosis
MR risk increases with 
severity of microcephalyReproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/110
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Tuberous sclerosis
Tuberous sclerosis is transmitted as an autosomal domi-
nant trait with variable expression and genetic heteroge-
neity, and occurs as a result of a de novo mutation in
approximately 60% of the patients. Multiple organs may
be involved including CNS skin, kidneys, heart and eyes.
Seizures are the most common presenting symptom and
are usually accompanied by mental retardation. Neuroim-
aging is the best diagnostic tool and is abnormal in 90%
of the cases. Computed tomography demonstrates sub-
ependymal calcified nodules and cortical or subcortical
areas of decreased attenuation (corresponding to tubers).
Magnetic resonance does not show calcified lesions well
but demonstrates the tubers better. The tubers are com-
posed of clusters of heterotopic cells and are indicative of
a migration disorder associated with abnormal cell differ-
entiation [38].
Prenatal diagnosis of cortical tubers may be considered in
affected families and in fetuses following ultrasono-
graphic visualization of a cardiac rhabdomyoma and are
therefore at risk of having tuberous sclerosis [39,40].
Sonigo et al studied 8 fetuses with multiple cardiac tumors
[39]. In all their patients the antenatal sonographic evalu-
ation of the brain was considered normal but fetal MRI
demonstrated hyperintense subependymal and cortical
nodules on T1-weighted images in 5 patients while in one
the nodules were only demonstrated after delivery [39].
Sgro et al reported the prenatal ultrasonographic diagno-
sis of tuberous sclerosis at 30 weeks of gestation with con-
firmation by postnatal US, CT and MRI [40].
In affected families and in fetuses with cardiac tumors vis-
ualization of brain nodules should be attempted by MRI.
However, failure of visualization does not provide com-
Flow chart in patients with suspected macrocephaly Figure 4
Flow chart in patients with suspected macrocephaly.
Head Circumference > 2SD
History: consanguinity, familial macrocephaly
HC measurement of both parents & siblings
 Positive history
Positive examination
 Familial large HC
Usually good prognosis
But occasionally MR
Follow up every 3 wks
No history
Family with normal HC
Overgrowth Syndrome?
Leukodystrophy?
Skeletal dysplasia?
Fetal Neurosonography, Fetal brain MRI
Counseling according to
specific diagnosis 
 Search for associated anomalies
NF1: Hypoplastic long bones
Soto: LGA, mild ventriculomegaly,
dolicocephaly, micrognathia,
hypertelorism
Weaver: LGA, hypertelorism, club 
    foot, contractures
Matchs: hamartomata, lipomatosis
Skeletal dysplasias: short bones
Detailed physical examination 
for stigmata of AD conditions
Negative examinationReproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/110
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plete reassurance that the newborn will not suffer from
tuberous sclerosis.
Cortical dysplasia with balloon cells
The diagnosis of cortical dysplasia with balloon cells
(CDBC) is based on the presence of focal cortical dyspla-
sia with balloon cells without concurrent manifestations
of TS. It is not clear if CDBC and TS represent different
entities or if they are different clinical and radiological
expressions of the same disease [41]. Most of the patients
present with seizures and are often refractory to medical
treatment [41].
The prenatal diagnosis of cortical dysplasia with balloon
cells has not been reported but must be considered in
cases with suspected focal cortical anomalies as demon-
strated by US or MRI.
Hemimegalencephaly
Hemimegalencephaly (HME) is a rare congenital malfor-
mation characterized by unilateral enlargement of the cer-
ebral hemisphere. It may present as an isolated finding or
in conjunction with neurocutaneous disorders [17]. HME
is considered a primary disturbance in cellular lineage,
differentiation and proliferation, interacting with a distur-
bance in gene expression of body symmetry [41].
All patients have seizures that are usually intractable and
most are mentally retarded [42]. HME has characteristic
imaging findings that include: asymmetry of the hemi-
spheres with a pathologically enlarged side, abnormal
gyral pattern, ventriculomegaly and abnormally thick-
ened white matter [43]. Associated CNS pathologies
(agenesis of the corpus callosum, Dandy-Walker malfor-
mation or abnormal cerebellum) may be present.
The prenatal diagnosis of HME has been reported in at
least 4 occasions [16,44-46] at 32 [44], 20 [45] and 22
weeks [46]. The diagnosis was suspected due to unilateral
ventricular dilatation with a shift of the falx cerebri. We
recently reported an additional fetus with HME [16]. The
referral diagnosis at 25 weeks was asymmetric ventricu-
lomegaly, but during the transvaginal neurosonographic
examination abnormal sulci and gyri and abnormal periv-
entricular echogenicity on the affected side were observed.
An MRI established the diagnosis of HME at 29 weeks and
final confirmation was achieved by the pathological
examination after the termination of pregnancy.
Neoplastic cell proliferation disorders
These entities are extremely rare. Chung et al reported on
the prenatal diagnosis of an enlarging intracranial mass
that proved to be a gangliocytoma [47]. Even with the use
of neurosonography or MRI the differential diagnosis of
fetal intracranial tumors will remain difficult and in most
cases the diagnosis will be made postnatally.
Conclusion
Obstetricians often encounter the diagnostic dilemma
presented by abnormal fetal head growth. Although the
developmental outcome in most cases is good, a maximal
effort should be made to reduce the chances of misdiag-
nosis of one of the multiple syndromes that can present
with fetal microcephaly or macrocephaly.
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